OzmoCAP®, a division of FreeThink Technologies, produces the latest in osmotic drug delivery technology.
The company’s flagship proprietary technology, the extended release capsule, is an oral osmotic capsule that provides a range of drug release durations controlled by the capsule, instead of the drug’s properties.
Who We Are
Dr. Kenneth Waterman
After receiving his B.S. (UCLA) and Ph.D. (UC Berkeley) in physical-organic chemistry, Kenneth Waterman completed post-doctoral studies (Columbia University) before spending 12 years at Polaroid (as a distinguished scientist), then 13 years at Pfizer (as a Research Fellow). He has successfully invented and commercialized a number of products and is the author of over 75 publications. He was made an AAPS Fellow in 2011, the same year he started FreeThink Technologies.
Dr. Jennifer Chu
Technology Development Lead
Jennifer Chu received her B.S.E. (Princeton University) and Ph.D. (University of Texas, Austin) before spending seven years at Pfizer (as a Senior Principal Scientist), followed by work at a series of small biotech companies (Neurogen, Ikaria, Achillion as an Executive Director of Pharmaceutical Sciences). She joined FreeThink in 2018, where she leads formulation development and manages FreeThink’s new technology development.
Business Development Manager
Dave received his B.S. from Springfield College and has >20 years of pharmaceutical industry experience, including pharmaceutical sciences supply chain management and clinical development operations. While at Pfizer, Dave was a senior leader on the industry’s first full-scale flexible resource model for global clinical trial management, and in 2013 he founded the consulting firm Verdure Bay to offer flexible expertise in product development. Dave joined FreeThink in 2018 to help lead global business development strategy and execution.